Apollo Hospitals Enterprise Limited vs Beta Drugs Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Beta Drugs Limited (BETA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Apollo Hospitals Enterprise Limited vs Beta Drugs Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation22
  • Profitability13
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
43.74
13.46
P/B ratio
9.41
0.22%
Dividend yield
0.00%
₹135.04
EPS
₹40.92

Profitability

BETA takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
16.95%
17.31%
Return on capital
17.76%
14.94%
EBITDA margin
19.67%
7.94%
Net margin
10.78%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
19.24%
33.35%
Profit CAGR (3Y)
10.19%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹1,983 Cr
₹25,229 Cr
Revenue
₹385 Cr
₹2,003 Cr
Net profit
₹41 Cr
0.90
Debt / equity
0.60
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.97 times its book value"]
Beta Drugs Limited
  • + ["Company has delivered good profit growth of 28.2% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 22.7%", "Company has delivered good sales growth of 27.1% CAGR over last 5 years"]
  • − ["Stock is trading at 8.10 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend"]
Apollo Hospitals Enterprise Limited full analysis Beta Drugs Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.